More than half of patients (53%) stop using GLP-1s within the first year, according to a December 2025 Sermo survey of physicians
| Weeks | Dose | Purpose | |---|---|---| | 1 to 4 | 0.25 mg once weekly | Tolerability induction | | 5 to 8 | 0.5 mg once weekly | Minimum effective therapeutic dose | | 9 to 12 (optional) | 1.0 mg once weekly | Enhanced glycemic control | | 13 to 16 (optional) | 1.7 mg once weekly | Bridge to maximum dose | | 17+ (optional) | 2.0 mg once weekly | Maximum approved dose for T2D | Dose advancement is not mandatory at every step
Nevertheless, further studies are needed to assess the safety, tolerability, and clinical effectiveness of Dula in therapy and focus on intestinal mucosal healing
The strength gains from Anavar often surprise first-time users
"Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms"
The majority of the tumors were found in the liver, followed by cases in the lung, soft tissue, and then bone
